Brief: Silo Pharma Secures Australian Patent Covering Licensed Ptsd Drug Candidate Expanding Global Ip Portfolio
03/09/2025 14:00
Sept 3 (Reuters) - Silo Pharma Inc SILO.O: SILO PHARMA SECURES AUSTRALIAN PATENT COVERING LICENSED PTSD DRUG CANDIDATE EXPANDING GLOBAL IP PORTFOLIO Source text: ID:nGNX5gmp2l Further company coverage: SILO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Silo Pharma
See all newsBrief: Silo Pharma - Enters Asset Purchase Agreement With Larry King On October 13, 2026 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Norsight Consulting On Oct 1 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting
Brief: Silo Pharma Selling Shareholders Offer On Resale Basis 1.9 Million Shares Of Silo Pharma Common Stock - SEC Filing
Brief: Silo Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement